Atlas Trials

Angioshield First-In-Human Study to Demonstrate the Preliminary Safety and Efficacy

Clinical trial NCT02072239 · COMPLETED

Trial details

NCT number
NCT02072239
Sponsor
Neograft Technologies, Incorporated
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Coronary Artery Disease
Start date
2014-02-01
Primary completion
2014-09-01
Enrollment
13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.